Results 181 to 190 of about 14,990 (249)

Allergic bronchopulmonary aspergillosis in India

Clinical and Experimental Allergy, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune‐mediated reactions mounted against Aspergillus fumigatus. The disorder most commonly complicates the course of patients with asthma and cystic fibrosis.
R. Agarwal   +4 more
semanticscholar   +1 more source

Long‐term follow‐up of allergic bronchopulmonary aspergillosis treated with glucocorticoids: A study of 182 subjects

Mycoses (Berlin), 2023
The long‐term outcomes of allergic bronchopulmonary aspergillosis (ABPA) are poorly characterised.
R. Agarwal   +8 more
semanticscholar   +1 more source

Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis

Seminars in Respiratory and Critical Care Medicine, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to airway colonization by Aspergillus fumigatus in patients with asthma and cystic fibrosis. The pathophysiology of ABPA involves a complex interplay between the fungus
R. Agarwal, V. Muthu, I. Sehgal
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy